Elise Hauge

Takeda Pharmaceuticals International GmbH develops, manufactures, and distributes pharmaceutical products. It offers medicines in therapeutic areas, such as, cardiovascular and metabolic, oncology, central nervous system, respiratory and immunology, general medicine, and vaccines. The firm also provides packaging, development, contract manufacturing and quality control services. Takeda Pharmaceuticals International was founded in 1874 and is headquartered in Zurich, Switzerland.

Takeda A/S engages in holding or owning of securities in other companies other than banks. The company was founded on January 4, 2005 and is headquartered in Taastrup, Denmark.

Nordea Bank AB engages in the provision of commercial banking services, life insurance, investment advice, and funds. It operates through the following segments: Personal Banking, Commercial & Business Banking, Wholesale Banking, Wealth Management, Group Finance & Treasury, and Other Operating segments. The Personal Banking segment serves the household customers of Nordea in the Nordic markets, through various channels offering a full range of financial services and solutions. The Commercial & Business Banking segment services large corporate customers and small and medium-sized corporate customers. The Wholesale Banking segment provides banking and other financial solutions to large Nordic and international corporate, institutional and public companies. The Wealth Management segment provides investment savings and risk management products. The Group Finance & Treasury segment manages the funding of the group and supports the management and control of the Nordea Group. The company was founded in 1820 and is headquartered in Stockholm, Sweden.